Fact CheckerSign in

NCT06069258Recruiting

Movement Behaviours Among Bahraini Diabetics

Movement Behaviours Among Bahraini Type 2 Diabetic Adults: a Cross-sectional Study

Source: ClinicalTrials.gov · Last updated 26 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes. The main objectives are: (i) Measure free-living physical activity and sedentary behaviour with an accelerometer device (ii) Examine associations between movement behaviours and anthropometric and diabetes-related biochemical/clinical parameters (iii) Examine associations between movement behaviours and psychological and environmental determinants that influence movement behaviours (iv) Assess the feasibility and acceptability of the physical activity assessment tools as part of routine clinical practice with clinicians and diabetic patients Participants will be invited to wear an accelerometer device for seven days.

Status (registry)
Recruiting
Study type
Observational
Enrollment
340 (estimated)
First submitted
1 Oct 2023
Start date
24 Apr 2024
Primary completion date
31 Dec 2025
Lead sponsor
Royal College of Surgeons in Ireland - Medical University of Bahrain
NCT number
NCT06069258

What you commit to

  • Study type: Observational
  • Planned participants: 340
  • From 24 Apr 2024 to the primary completion date, 31 Dec 2025
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 diabetes
  • Non-ambulant or severely incapacitated with any medical condition(s) reducing ability to stand or mobilize.

Lab values

  • HbA1c \>9%

Other

  • Taking insulin
  • Pregnancy
  • Currently participating in a study to reduce sedentary behaviour or increase physical activity
  • Language. Inability to read and understand Arabic or English language.
  • Inability to give informed consent.

Who the study is looking for

  • Sex: Men and women are eligible.
  • Age: Individuals aged 20-75 years old are eligible.
  • Ethnicity: Bahraini adults of all ethnic groups are eligible for the study.
  • Type 2 diabetes and glycaemic control: Individuals with controlled type 2 diabetes (i.e. HbA1c \<9 on medication) based on the medical record of each patient's last visit to the health centre for routine follow-up will be eligible if within the last four months. Otherwise, these measurements will be ordered at the first visit to confirm eligibility.
  • Blood pressure: Individuals whose blood pressure is under moderate control will be eligible - specifically, treated or untreated resting systolic/diastolic pressure \< 160/100 mmHg.
  • Lipid control: Individuals with fasting triglyceride concentration \< 600 mg are eligible.

Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Isa Town Health Centre
Coordinator of this site? Confirm its status
Building 10, Road 43BahrainRecruiting
Ahmed Ali Kanoo Health Centre
Coordinator of this site? Confirm its status
Building 2009, Road 2641BahrainRecruiting
Halat Bu Maher Health Centre
Coordinator of this site? Confirm its status
Building 2858, Road 1653BahrainNot yet recruiting
Shaikh Jaber AlSabah Health Centre
Coordinator of this site? Confirm its status
Building 6347, Road Nakheel StreetBahrainNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.